Within this frame, we reckon that T2 RNases (and human RNASET2 in particular), due to their established “multitasking” oncosuppressor activity carried out at both cell-autonomous and non-cell-autonomous levels, might represent a very promising and innovative anti-cancer tool. Here, RNASET2 is linked to cancer.